These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Xiao YL; Peng S; Tao J; Wang AJ; Lin JK; Hu PJ; Chen MH Am J Gastroenterol; 2010 Dec; 105(12):2626-31. PubMed ID: 20823838 [TBL] [Abstract][Full Text] [Related]
15. Review article: current and emerging therapies for functional dyspepsia. Saad RJ; Chey WD Aliment Pharmacol Ther; 2006 Aug; 24(3):475-92. PubMed ID: 16886913 [TBL] [Abstract][Full Text] [Related]
16. [Role of acid in functional dyspepsia]. Tomita T; Oshima T; Fukui H; Watari J; Miwa H Nihon Rinsho; 2015 Jul; 73(7):1202-8. PubMed ID: 26165081 [TBL] [Abstract][Full Text] [Related]
18. The Rome III Classification of dyspepsia: will it help research? Talley NJ; Ruff K; Jiang X; Jung HK Dig Dis; 2008; 26(3):203-9. PubMed ID: 18463436 [TBL] [Abstract][Full Text] [Related]
19. Current medical treatments of dyspepsia and irritable bowel syndrome. Camilleri M; Tack JF Gastroenterol Clin North Am; 2010 Sep; 39(3):481-93. PubMed ID: 20951913 [TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease. Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]